This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosenbloom, A. L. Articles by Parks, J. S. Search for Related Content PubMed PubMed Citation Articles by Rosenbloom, A. L. Articles by Parks, J. S.

Clinical and Biochemical Phenotype of Familial Anterior Hypopituitarism from Mutation of the PROP1 Gene¹

Department of Pediatrics, University of Florida, Children’s Medical Services Center (A.L.R.), Gainesville, Florida 32608; Centro Medico National (A.S.A.), Santo Domingo, Dominican Republic; Department of Pediatrics, Emory University (M.R.B.), Atlanta, Georgia; Quest Diagnostics, Inc.-Nichols Institute Diagnostics (D.A.F.), San Juan Capistrano, California 92690; Department of Pediatrics, University of Miami (L.B.), Miami, Florida 33101; and the Department of Pediatrics, Emory University (J.S.P.), Atlanta, Georgia 30322

Address all correspondence and requests for reprints to: Dr. Arlan L. Rosenbloom, Department of Pediatrics, University of Florida, Children’s Medical Services Center, 1701 SW 16th Avenue, Gainesville, Florida 32608.

We have investigated the largest family with PROP1 deficiency reported to date. Eight patients, aged 17–40 yr, in two sibships with possibly related mothers but no parental consanguinity were 109–137 cm in height (-8.8 to [minsu]5.9 SD score) and sexually immature. None had received hormonal therapy. Affected individuals had similarities to and significant differences from patients with insulin-like growth factor I (IGF-I) deficiency due to GH receptor deficiency (GHRD) and normal thyroid function and sexual maturation. The differences from patients with GHRD include normal hand and foot length in seven of eight, normal arm span with relatively long legs, and persistence of extremely low levels of IGF-I into adulthood; similarities include the degree of growth failure, frequent but not uniform increased body weight for height or body mass index, and the presence of limited elbow extensibility and blue scleras in six of eight. Three patients had markedly increased sella turcica area for height age and bone age, determined from lateral skull films. The degree of sellar enlargement is variable in these two sibships.

Serum GH concentrations were 0.1 ng/mL or less after clonidine ingestion. Other results were: IGF-I, 3–11 ng/mL (normal, 114–492); IGF-II, 185–299 ng/mL (normal, 358–854); IGF-binding protein-1 (IGFBP-1), 12–200 ng/mL (normal, 13–73); IGFBP-2, 60–384 ng/mL (normal, 55–480); and IGFBP-3, 400–600 ng/mL (normal, 2000–4000). The very low IGF-I and normal IGFBP-1 and -2 levels differ from findings in adults with GHRD. The GH-binding protein concentration was 58–799 pmol/L, with two patients above the normal range of 66–306. LH and FSH levels were very low, with no sex differences between serum levels of estradiol (3–6 pg/mL) and testosterone (3–10 ng/dL). PRL levels all were below normal. Serum concentrations of cortisol were normal. Serum T₄ levels were uniformly low (<0.2–0.5; normal, 0.8–2.7 ng/dL), free T₃ values were less than normal in seven of eight subjects, and total T₃ concentrations were below normal in five of eight, but TSH levels were normal (0.58–2.18; normal, 0.4–4.2 mU/L).

DNA specimens from affected individuals in each sibship were homozygous for a 2-bp deletion in exon 2 of the PROPI (Prophet of Pit-I) gene, which causes a shift of reading frames and results in a translational stop signal at codon 109. The mutant protein, when expressed in vivo lacks DNA-binding and transcriptional activation functions. The consequences of the PROPI abnormality in this and other kindreds include gonadotropin deficiency as well as the expected deficiencies in products of Pit-I-dependent somatotrophs, lactotrophs, and thyrotrophs. The severity of the hormone deficiency phenotype is compatible with the complete loss of PROP1 activity.

This article has been cited by other articles:

				L.L.F. do Amaral, R.M. Ferreira, N.P.F.D. Ferreira, R.A. Mendonca, V.H.R. Marussi, J.L. da Cunha, B.R. Macaranduba, and J.D. Medeiros Combined Pituitary Hormone Deficiency and PROP-1 Mutation in Two Siblings: A Distinct MR Imaging Pattern of Pituitary Enlargement AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1369 - 1370. [Abstract] [Full Text] [PDF]

				M J E Walenkamp and J M Wit Genetic disorders in the GH IGF-I axis in mouse and man Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S15 - S26. [Abstract] [Full Text] [PDF]

				J. Lebl, J. Vosahlo, R. W Pfaeffle, H. Stobbe, J. Cerna, D. Novotna, J. Zapletalova, B. Kalvachova, V. Hana, V. Weiss, et al. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects Eur. J. Endocrinol., September 1, 2005; 153(3): 389 - 396. [Abstract] [Full Text] [PDF]

				M. J. E. Walenkamp, M. Karperien, A. M. Pereira, Y. Hilhorst-Hofstee, J. van Doorn, J. W. Chen, S. Mohan, A. Denley, B. Forbes, H. A. van Duyvenvoorde, et al. Homozygous and Heterozygous Expression of a Novel Insulin-Like Growth Factor-I Mutation J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2855 - 2864. [Abstract] [Full Text] [PDF]

				P. E Mullis Genetic control of growth Eur. J. Endocrinol., January 1, 2005; 152(1): 11 - 31. [Abstract] [Full Text] [PDF]

				R. Reynaud, M. Chadli-Chaieb, S. Vallette-Kasic, A. Barlier, J. Sarles, I. Pellegrini-Bouiller, A. Enjalbert, L. Chaieb, and T. Brue A Familial Form of Congenital Hypopituitarism Due to a PROP1 Mutation in a Large Kindred: Phenotypic and in Vitro Functional Studies J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5779 - 5786. [Abstract] [Full Text] [PDF]

				J. K. Lee, Y.-S. Zhu, J. J. Cordero, L.-Q. Cai, I. Labour, C. Herrera, and J. Imperato-McGinley Long-Term Growth Hormone Therapy in Adulthood Results in Significant Linear Growth in Siblings with a PROP-1 Gene Mutation J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4850 - 4856. [Abstract] [Full Text] [PDF]

				A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J. F. W. Weigel, A. Keller, W. Hirsch, W. Kiess, W. F. Blum, and R. W. Pfaffle PROP1 Mutations Cause Progressive Deterioration of Anterior Pituitary Function including Adrenal Insufficiency: A Longitudinal Analysis J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5256 - 5265. [Abstract] [Full Text] [PDF]

				A. Voutetakis, M. Argyropoulou, A. Sertedaki, S. Livadas, P. Xekouki, M. Maniati-Christidi, I. Bossis, N. Thalassinos, N. Patronas, and C. Dacou-Voutetakis Pituitary Magnetic Resonance Imaging in 15 Patients with Prop1 Gene Mutations: Pituitary Enlargement May Originate from the Intermediate Lobe J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2200 - 2206. [Abstract] [Full Text] [PDF]

				R. J. Davenport Power to the People Sci. Aging Knowl. Environ., December 17, 2003; 2003(50): ns8 - 8. [Abstract] [Full Text] [PDF]

				R. N. Cohen, L. E. Cohen, D. Botero, C. Yu, A. Sagar, M. Jurkiewicz, and S. Radovick Enhanced Repression by HESX1 as a Cause of Hypopituitarism and Septooptic Dysplasia J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4832 - 4839. [Abstract] [Full Text] [PDF]

				T. C. Vieira, M. R. Dias da Silva, J. M. Cerutti, E. Brunner, M. Borges, L. T. Arnaldi, P. Kopp, and J. Abucham Familial Combined Pituitary Hormone Deficiency due to a Novel Mutation R99Q in the Hot Spot Region of Prophet of Pit-1 Presenting as Constitutional Growth Delay J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 38 - 44. [Abstract] [Full Text] [PDF]

				L. E. Cohen and S. Radovick Molecular Basis of Combined Pituitary Hormone Deficiencies Endocr. Rev., August 1, 2002; 23(4): 431 - 442. [Abstract] [Full Text] [PDF]

				S. N. Kalantaridou and G. P. Chrousos Monogenic Disorders of Puberty J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2481 - 2494. [Full Text] [PDF]

				F. G. Riepe, C.-J. Partsch, O. Blankenstein, H. Monig, R. W. Pfaffle, and W. G. Sippell Longitudinal Imaging Reveals Pituitary Enlargement Preceding Hypoplasia in Two Brothers with Combined Pituitary Hormone Deficiency Attributable to PROP1 Mutation J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4353 - 4357. [Abstract] [Full Text] [PDF]

				M. G. F. Osorio, P. Kopp, S. Marui, A. C. Latronico, B. B. Mendonca, and I. J. P. Arnhold Combined Pituitary Hormone Deficiency Caused by a Novel Mutation of a Highly Conserved Residue (F88S) in the Homeodomain of PROP-1 J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2779 - 2785. [Abstract] [Full Text]

				O. Fofanova, N. Takamura, E.-i. Kinoshita, A. Vorontsov, V. Vladimirova, I. Dedov, V. Peterkova, and S. Yamashita MR Imaging of the Pituitary Gland in Children and Young Adults with Congenital Combined Pituitary Hormone Deficiency Associated with PROP1 Mutations Am. J. Roentgenol., February 1, 2000; 174(2): 555 - 559. [Abstract] [Full Text] [PDF]

				F. Pernasetti, S. P. A. Toledo, V. V. Vasilyev, C. Y. Hayashida, J. D. Cogan, C. Ferrari, D. M. Lourenço, and P. L. Mellon Impaired Adrenocorticotropin-Adrenal Axis in Combined Pituitary Hormone Deficiency Caused by a Two-Base Pair Deletion (301-302delAG) in the Prophet of Pit-1 Gene J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 390 - 397. [Abstract] [Full Text]